Search clinical trials for: Placebo (sitagliptin)
Total 54029 results
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Dong Wha Pharmaceutical Co. Ltd.CompletedA Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersHealthy SubjectsKorea, Republic of
-
Chinese PLA General HospitalUnknownAtherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
-
University of DundeeCompletedDiabetes Mellitus, Type 2United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Boehringer IngelheimCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus Type 2Korea, Republic of
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
Wuhan General Hospital of Guangzhou Military CommandCompletedCoronary Artery Disease | Newly Diagnosed Type 2 DiabetesChina
-
Ludwig-Maximilians - University of MunichTerminated
-
Galenicum HealthCompletedType 2 Diabetes | BioequivalenceCanada
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceCanada
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Jothydev's Diabetes and Research CentreCompletedDiabetes Mellitus, Type 2India
-
VIVUS LLCCompleted
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
Merck Sharp & Dohme LLCPfizerCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Seoul National University Bundang HospitalAstellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
TheracosCompletedType2 Diabetes MellitusUnited States
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
University of CopenhagenRigshospitalet, DenmarkUnknown
-
GlaxoSmithKlineCompleted
-
Anna CrucetaCompletedDIABETES Mellitus Type 2 Not Well ControlledSpain
-
Taipei Veterans General Hospital, TaiwanUnknown
-
University of Sao Paulo General HospitalUniversity of Sao PauloCompletedDiabetes Type 2Brazil
-
The Catholic University of KoreaMSD Korea Ltd.UnknownType 2 DiabetesKorea, Republic of
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompletedType 2 DiabetesUnited Kingdom
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
Vanderbilt UniversityCompleted
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceMexico
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceMexico
-
Azienda Ospedaliero-Universitaria di ParmaActive, not recruitingNewly Diagnosed Type 2 DiabetesItaly
-
Ludwig-Maximilians - University of MunichCompletedAcute Myocardial InfarctionGermany
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
KineMedCompletedDiabetes Mellitus, Type 2United States
-
Vanderbilt UniversityCompletedHypertension | Type 2 Diabetes MellitusUnited States